
China Shineway Pharmaceutical Group Limited
2877.HKHKSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
HK$7.97
−HK$0.07 · -0.87%
2877.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteAs an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Zhenjiang Li
- Listed since
- Dec 2, 2004
- Employees
- 2,822
Market position
- Volume
- 601K
- 0.72× average
- Average volume
- 837.65K
- Average daily volume
- Market cap
- 6.04B HKD
- Beta
- 0.72
- Market reference 1
2877.HK peers
Continue in GoAI
Research 2877.HKresearch.disclaimer





